Reduction of distress in hyperprolactinemia with bromocriptine.
In a double-blind placebo-controlled crossover study of bromocriptine in eight hyperprolactinemic patients, self-rated distress decreased and well-being increased parallel with the fall in prolactin levels; for the majority of measures the differences were significant.
D000293:Adolescent; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006791:Hostility / Q000187:drug effects; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory; D011388:Prolactin / Q000097:blood*; D011897:Random Allocation; D013315:Stress, Psychological / Q000097:blood / Q000188:drug therapy*
D001971:Bromocriptine; D011388:Prolactin